Organic compounds

Details for Australian Patent Application No. 2009264220 (hide)

Owner Novartis AG

Inventors Hu, Qi-Ying; McQuire, Leslie Wighton; Adams, Christopher; Papillon, Julien

Agent Davies Collison Cave

Pub. Number AU-B-2009264220

PCT Pub. Number WO2009/156462

Priority 61/076,452 27.06.08 US

Filing date 25 June 2009

Wipo publication date 30 December 2009

Acceptance publication date 23 August 2012

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61K 31/4439

A61P 9/00 Drugs for disorders of the cardiovascular system

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

23 December 2010 PCT application entered the National Phase

  PCT publication WO2009/156462 Priority application(s): WO2009/156462

23 August 2012 Application Accepted

  Published as AU-B-2009264220

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009264237-Inhibitors of carnitinpalmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue

2009264214-Muteins of hNGAL and related proteins with affinity for a given target